A Trial of "APL-9796'' in Adults With Pulmonary Hypertension

NCT06846554 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: APL-9796
DRUG: APL-9796

Sponsor

Apollo Therapeutics Ltd